Page 119 - MemoriaEHD-Eng

www.ciberehd.org

• C MJ, C M, D e, B- a M, B F, i e. Safety
Most relevant asaNovahaparrooMèNeCharreiroDeCostaerMeJogLesias
of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory
scientific bowel disease.Am J Gastroenterol. 2013 Mar;108(3):433-40.

articles
• C M, o i, C e, g-s v, B g, p M. Safety of thio-
haparrorDásaBréarCíaaNChezastiDaeñaLva
purine therapy in inflammatory bowel disease: long-term follow-up study of 3931
patients.Inflamm Bowel Dis. 2013 Jun;19(7):1404-10.

• M-i J, r M, F-B M, F a, g ag, p L. Op-
oLiNaNFaNteoMaNoerNáNDezerMeJoeDeriCoraviNaozzati
timized nonbismuth quadruple therapies cure most patients with Helicobacter pylori
infection in populations with high rates of antibiotic resistance.Gastroenterology.

2013 Jul;145(1):121-128.e1.

• saNDBorN WJ, FeagaN Bg, rutgeerts p, haNauer s, CoLoMBeL JF, saNDs Be. Vedolizumab
as induction and maintenance therapy for Crohn’s disease.N Engl J Med. 2013 Aug

22;369(8):711-21.

• FeagaN Bg, rutgeerts p, saNDs Be, haNauer s, CoLoMBeL JF, saNDBorN WJ et aL.. Vedolizu-
mab as induction and maintenance therapy for ulcerative colitis.N Engl J Med. 2013

Aug 22;369(8):699-710.

ó

Highlights
In 2013 the group has focused on increasing its activity in European and international
contexts:

• Coordinates the ‘Pan-European Registry on Helicobacter pylori infection management’

in which 300 gastroenterologists from 31 European countries participate, making it
the largest study on an infectious agent.

• The United European Gastroenterology has granted this team a long-term educational

and research project entitled ‘Optimal H. pylori management in Primary Care’ aiming
to improve the knowledge and implementation of the ‘Maastricht IV European

Consensus on Helicobacter pylori infection’ in 9 European countries.
í
• The group is represented by its members in several international organizations

such as the European Helicobacter Study Group, the European Crohn’s and Colitis
Organization, the United European Gastroenterology, the American Gastroenterology

Association, the Iberoamerican Network for the Study of Helicobacter and the
Cochrane Collaboration.

The Group has also coordinated the following educative actions and transfer activities

(Clinical Guides):

• Actualizacin de Gastroenterologa Aplicada (Summary of the most relevant works
presented at the USA Digestive Disease Week congress). Accredited by the Spanish

Continuing Medical Education Council. Endorsed by the AEG.

• Post-ECCO Congress (Summary of the most relevant works presented at the
European Crohn’s and Colitis Organization Congress). Endorsed by the AEG and

GETECCU.
13
• ECCO Anaemia Consensus. European Consensus on the management of anaemia 20
in IBD. Dr. Gisbert has been the coordinator of the Prevention of iron deficiency T
OR
anaemia Working Group. Endorsed by the European Crohn’s and Colitis Organization
P
RE
• III Spanish Consensus Conference on H. pylori infection. Dr. Gisbert was the general L
A
coordinator. Endorsed by the AEG and the SEPD.
NU
N
National or international publications: 81 A
D /
1st decile publications: 17 H
1st quartile publications: 46 E
ER
Ongoing proyects: 26
IB
C
Defended dissertations / thesis: 5
119
Dissertations / thesis in preparation: 10